AK
Ashwani Kumar Tejpal
About Ashwani Kumar Tejpal
Data last updated:
Ashwani Kumar Tejpal is a Director at Uniphar Biotech Private Limited (since 2017), Director at Abiz Pharma Private Limited (since 2018) and Director at Logimed Pharma Private Limited (since 2017). The companies operate in Pharma and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹7.84 Cr; the largest is Uniphar Biotech Private Limited at ₹4.85 Cr (FY 2024). Earlier, Ashwani Kumar Tejpal was a Director at Arovea Lifesciences Private Limited (2018–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Apr 2017 | 2013 | ₹4.85 Cr (FY 2024) | Active | |
| Director | 13 Feb 2018 | 2018 | ₹2.18 Cr (FY 2025) | Active | |
| Director | 12 Apr 2017 | 2015 | ₹80.2 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Sep 2018 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ashwani Kumar Tejpal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Adesh Saini | 06675560 | Uniphar Biotech Private Limited , Abiz Pharma Private Limited | Director |
| Kamna Matta | 06675543 | Uniphar Biotech Private Limited , Abiz Pharma Private Limited | Director |
| Rajeev Matta | 05152655 | Uniphar Biotech Private Limited , Abiz Pharma Private Limited | Director |
| Vinay Chadha | 05152657 | Logimed Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashwani Kumar Tejpal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashwani Kumar Tejpal
Ashwani Kumar Tejpal currently holds 3 directorships: Uniphar Biotech Private Limited (Director, since 12 Apr 2017, revenue ₹4.85 Cr (FY 2024)); Abiz Pharma Private Limited (Director, since 13 Feb 2018, revenue ₹2.18 Cr (FY 2025)); Logimed Pharma Private Limited (Director, since 12 Apr 2017, revenue ₹80.2 Lakh (FY 2024)).
Ashwani Kumar Tejpal was first appointed on 12 Apr 2017 as Director at Uniphar Biotech Private Limited. The most recent appointment on record is 28 Sep 2018 at Arovea Lifesciences Private Limited.
The 3 current companies of Ashwani Kumar Tejpal that report revenue have a combined latest revenue of ₹7.84 Cr: Uniphar Biotech Private Limited ₹4.85 Cr (FY 2024); Abiz Pharma Private Limited ₹2.18 Cr (FY 2025); Logimed Pharma Private Limited ₹80.2 Lakh (FY 2024).
Ashwani Kumar Tejpal held 1 earlier board appointment: Arovea Lifesciences Private Limited (Director, 28 Sep 2018 to 10 Feb 2021).
The current boards of Ashwani Kumar Tejpal's companies include Adesh Saini (Uniphar Biotech Private Limited), Kamna Matta (Uniphar Biotech Private Limited), Rajeev Matta (Uniphar Biotech Private Limited), Vinay Chadha (Logimed Pharma Private Limited).